Search

everythinglearnresearchcommunity

for

Search:↓

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

Chemotherapy often causes skin and hair issues, but early management can help improve patient care.

Vemurafenib causes skin side effects similar to RASopathies, requiring regular skin checks and UVA protection.

Reducing gefitinib dosage improved hair loss, but scarring remained.

Selumetinib causes skin and hair side effects in kids with NF1, affecting treatment and quality of life.

Patients on dabrafenib and trametinib for melanoma often experience skin side effects.

Marine algae compounds may improve skin health and promote hair growth.

Depression may be linked to changes in body electrolytes and muscle inactivity, similar to effects of weightlessness.

Many patients on methotrexate experience significant side effects but still continue the medication.

Phlorotannins from brown seaweeds may improve skin and hair health in cosmetics.

Oxytocin receptors are found in skin cells near touch and pain neurons.

Selumetinib effectively reduces tumor size in many children with neurofibromatosis type 1, but can cause skin and hair issues.

Cancer drugs often cause temporary hair, skin, nail, and mouth issues.

New cancer drugs can cause skin side effects like rashes, dry skin, hair changes, and nail problems.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

The Wnt/β-catenin pathway is important for body functions and diseases, and targeting it may treat conditions like cancer, but with safety challenges.

Antihepcidin antibodies may treat inflammation-induced anemia by improving iron metabolism.

Current skin substitutes help heal severe burns but don't fully replicate natural skin features.

Chitosan, a natural substance, can be used to create tiny particles that effectively deliver various types of drugs, but more work is needed to improve stability and control of drug release.

Tyrosine kinases are important in skin autoimmune diseases and could be targets for new treatments.

Afatinib often causes skin problems that need proactive management.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

Epidermal Growth Factor helps hair follicle cells grow and move by activating a specific cell signaling pathway.

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

Overexpressing the epigen gene in mice leads to enlarged sebaceous glands and greasy fur.

Skin reactions from cancer treatments might predict how well the treatments work.

Photobiomodulation therapy helps manage cancer treatment side effects but needs more research for optimization.

A woman poisoned with thallium was successfully treated with activated charcoal and Prussian blue.

Targeting regulatory T cells may help treat age-related diseases.

Targeted anticancer therapies in children often cause skin side effects like rash and dry skin.